How much does Sorafenib cost per month after medical insurance?

The original drug Sorafenib (Sorafenib) has been launched in China and has entered the scope of medical insurance. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The price of 0.2g*60 tablets may be around 1,200 yuan, and this drug may be sold in domestic pharmacies or hospitals. Sorafenib is widely used in the treatment of malignant tumors such as hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), and thyroid cancer. It has some advantages over traditional chemotherapy drugs, such as better selectivity, less toxic side effects, and a predictable mechanism of action. However, in some cases, sorafenib can also be used in combination with traditional chemotherapy drugs or other targeted therapies to improve the therapeutic effect.